See how top analysts and institutions rate QXO — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Vertical Research | Initiated | Buy | $30 | 2025-10-21 |
| KeyBanc Capital Markets | Initiated | Overweight | $28 | 2025-10-01 |
| Raymond James | Initiated | Outperform | $28 | 2025-09-05 |
| Morgan Stanley | Initiated | Overweight | $35 | 2025-09-02 |
| The Benchmark Company | Initiated | Buy | $50 | 2025-08-22 |
| Stephens | Initiated | Overweight | $29 | 2025-08-13 |
| Wells Fargo | Initiated | Overweight | $30 | 2025-08-05 |
| RBC Capital Mkts | Initiated | Outperform | $33 | 2025-07-21 |
| Citigroup | Initiated | Buy | $33 | 2025-07-16 |
| Truist | Initiated | Buy | $30 | 2025-07-01 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| December 2025 | 3 | 13 | 0 | 0 | 0 |
| November 2025 | 3 | 12 | 0 | 0 | 0 |
| October 2025 | 3 | 12 | 0 | 0 | 0 |
| September 2025 | 3 | 11 | 0 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for QXO, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
